Inventiva (IVA) Asset Utilization Ratio (2021 - 2025)
Inventiva (IVA) posted quarterly Asset Utilization Ratio of 0.0 for Q2 2021, up 5.44% quarter-over-quarter from 0.0 in Q1 2021.
Analysis
Inventiva (IVA) Asset Utilization Ratio (2021 - 2025) Analysis & Trends
Inventiva's Asset Utilization Ratio history runs 2 years deep, the most recent figure standing at 0.0 for Q2 2021.
- In Q2 2021, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM figure through Jun 2021 stood at 0.0 (changed N/A YoY), while the FY2025 annual figure was 0.04, down 71.64% from the prior year.
- Asset Utilization Ratio for Q2 2021 stood at 0.0, up from 0.0 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.07 in Q4 2020, with the low at 0.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 0.20 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 0.69 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 0.90 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.13 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 0.54 |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -0.02 |
| Jun 30, 2024 | 0.09 |
| Jun 30, 2022 | 0.00 |
| Jun 30, 2021 | 0.00 |